p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2

被引:144
作者
Aliouat-Denis, CM
Dendouga, N
Van den Wyngaert, I
Goehlmann, H
Steller, U
van de Weyer, I
Van Slycken, N
Andries, L
Kass, S
Luyten, W
Janicot, M
Vialard, JE
机构
[1] Johnson & Johnson Pharmaceut Res & Early Dev, Oncol Discovery Res & Early Dev, B-2340 Beerse, Belgium
[2] Johnson & Johnson Pharmaceut Res & Early Dev, Adv BioTechnol, B-2340 Beerse, Belgium
[3] Johnson & Johnson Pharmaceut Res & Early Dev, Genom Technol, B-2340 Beerse, Belgium
[4] Histogenex, Edegem, Belgium
关键词
D O I
10.1158/1541-7786.MCR-05-0121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Chk2 kinase is a tumor suppressor and key component of the DNA damage checkpoint response that encompasses cell cycle arrest, apoptosis, and DNA repair. It has also been shown to have a role in replicative senescence resulting from dysfunctional telomeres. Some of these functions are at least partially exerted through activation of the p53 transcription factor. High-level expression of virally transduced Chk2 in A549 human lung carcinoma cells led to arrested proliferation, apoptosis, and senescence. These were accompanied by various molecular events, including p21(Waf1/CiP1) (p21) transcriptional induction, consistent with p53 activation. However, Chk2-dependent senescence and p21 transcriptional induction also occurred in p53-defective SK-BR-3 (breast carcinoma) and HaCaT (immortalized keratinocyte) cells. Small interfering RNA-mediated knockdown of p21 in p53-defective cells expressing Chk2 resulted in a decrease in senescent cells. These results revealed a p53-independent role for Chk2 in p21 induction and senescence that may contribute to tumor suppression and genotoxic treatment outcome.
引用
收藏
页码:627 / 634
页数:8
相关论文
共 41 条
  • [1] The Chk2 protein kinase
    Ahn, J
    Urist, M
    Prives, C
    [J]. DNA REPAIR, 2004, 3 (8-9) : 1039 - 1047
  • [2] Ahn JY, 2000, CANCER RES, V60, P5934
  • [3] Chk2 kinase - A busy messenger
    Bartek, J
    Falck, J
    Lukas, J
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) : 877 - 886
  • [4] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [5] Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: Checkpoint activation as a strategy against cancer
    Chen, CR
    Wang, WX
    Rogoff, HA
    Li, XT
    Mang, W
    Li, CJ
    [J]. CANCER RESEARCH, 2005, 65 (14) : 6017 - 6021
  • [6] d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
  • [7] DNA damage induces p53-dependent down-regulation of hCHK1
    Damia, G
    Sanchez, Y
    Erba, E
    Broggini, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 10641 - 10645
  • [8] TRANSFORMING GROWTH-FACTOR-BETA INDUCES THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 THROUGH A P53-INDEPENDENT MECHANISM
    DATTO, MB
    LI, Y
    PANUS, JF
    HOWE, DJ
    XIONG, Y
    WANG, XF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5545 - 5549
  • [9] Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin
    De Schepper, S
    Bruwiere, H
    Verhulst, T
    Steller, U
    Andries, L
    Wouters, W
    Janicot, M
    Arts, J
    Van Heusden, J
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (02) : 881 - 888
  • [10] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367